PLEASANTON, Calif., March 22, 2018 -- Co-founder and CEO of Title21 Health Solutions (www.Title21.com) Lynn Fischer will share her purpose-driven career story on The MENTORS RADIO SHOW this weekend. Listeners can hear the interview live on KTRB AM860 San Francisco at 7am PT on Saturday, March 24 and at noon on Sunday, March 25; and KCBQ AM1170 San Diego at 12pm PT Saturday, March 24; and on-demand anytime on TheMentorsRadio.com. Title21 Health Solutions is an innovative technology company in the San Francisco Bay Area that delivers integrated, easy-to-use Cloud Enterprise Quality Management Systems and end-to-end software that digitizes cell and gene manufacturing and bone marrow transplant programs.
Hosted by Mentor Tom Loarie, Ms. Fischer tells her story of pivoting a successful consumer packaged goods Marketing career with Gallo Winery, Dreyer’s Grand Ice Cream, M&M/Mars and The Wine Group to lead a patient-centric healthcare technology company. Lynn discusses how her passion to make a difference and improve patient quality and outcomes were the motivating factors to make the move to healthcare. “At the age of fifteen my Dad and mentor was diagnosed with melanoma, and Memorial Sloan Kettering Cancer Center saved his life. That experience had a profound impact on my desire to support the advancement of innovative, curative therapies through technology.”
Host, Tom Loarie stated, “Anyone considering a major career pivot will be inspired by Lynn’s story which reminds us that anything is possible when you allow your purpose and passion to steer your career journey.”
Ms. Fischer remarks, “I hope my career story will inspire others to lead with their heart and pursue a career that serves others even if it requires a pivot. Wine to healthcare technology was a big jump. If I can do it, anyone can.”
About Title21 Health Solutions
Title21 Health Solutions continues to gain national recognition for its innovative technology to help hospitals, biotechnology, regenerative medicine and other health science organizations improve quality, efficiency and patient safety. Title21’s product line includes web-based quality management solutions and the first end-to-end cell and gene therapy software available in the market. Learn more about Title21 and rewarding careers at www.Title21.com.
Media Contact Haley Roebuck [email protected]


Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Washington Post Publisher Will Lewis Steps Down After Layoffs
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 



